Search results for: 'cmos imaging sensor case'
- Related search terms
- sensor fusion rapid portfolio and growth opportunity analysis
- case study m&a
- sensor fusion rail portfolio ad growth opportunity analysis
- sensor fusion rail portfolio ad growth opportunity analysi
- sensor fusion radar portfolio ad growth opportunity analysis
-
24 Dec 2019  |  North America  |  Frost Radar
Frost Radar in the Global LiDAR Market
A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines
Zero road fatalities is a goal for legislators, automotive suppliers, and original equipment manufacturers. To achieve this, major automotive companies are exploring autonomous driving technologies to complement their vehicle lineups’ active safety portfolios. Frost & Sullivan research found that the advanced driver assistance systems (ADAS) marke...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 May 2022  |  North America  |  Market Outlook
Global Advanced Driver Assistance Systems (ADAS) and Autonomous Driving (AD) Industry, Outlook 2022
Future Growth Potential Enhanced by Opportunities in Assisted, Piloted Driving and Automated Vehicle Parking Features
The automotive industry is among the most affected by the COVID-19 pandemic and the ongoing semiconductor shortage. The resulting economic crisis impacted overall vehicle sales, leading to a delay in value chain components supply and technology introduction and a shift in consumer preferences. Original equipment manufacturers (OEMs) and value ch...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Aug 2024  |  Global  |  Technology Research
Technological Advances in Regenerative Medicine
Disruptive Technology and a Competitive Landscape Drive Growth in Stem Cell Therapy Research
Regenerative medicine has evolved significantly and today includes several commercialized stem cell therapies. Researchers have made notable technological developments in stem cell therapies to overcome challenges related to large-scale manufacturing and cell quality. Stem cell research is more focused on induced pluripotent stem cells than on mese...
$4,950.00
Special Price $4,207.50 save 15 %
-
23 Jan 2026  |  Global  |  Technology Research
Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...
$950.00 -
02 Nov 2026  |  Global  |  Market Research
Continuous Glucose Monitoring Market, Global, 2026
CGM Market is Experiencing Transformational Growth Driven by Decentralized Molecular Diagnostics, Ultra-Rapid Testing, and Connected Clinical Intelligence Ecosystems
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-counter (OTC) CGM, growing adoption among non-insulin...
$2,450.00 -
24 Nov 2014  |  North America  |  Market Research
Strategic Analysis of the North American and European Tire Pressure Monitoring Systems Aftermarket
Market Size to Triple Over the Next 5 to 7 Years
This research service analyzes the tire pressure sensors aftermarket in North America and Europe. Frost & Sullivan forecasts high growth in both regions because of battery expiration in North America and winter tire sales in Europe. The study includes unit shipment and revenue forecasts; pricing, distribution channel, and market share analyses; mar...
$3,950.00
Special Price $2,962.50 save 25 %
-
19 Dec 2011  |  North America  |  Market Research
DoD Airborne ISR Market
The Continuing Shift from Manned to Unmanned ISR Platforms
This research forecasts the U.S. Airborne intelligence, surveillance, and reconnaissance (ISR) market. The goal of Airborne ISR is to provide the warfighter with near real-time threat identification, tracking, targeting, and attack as well as battlefield situational awareness data such as imagery, video, and signals intelligence. The Airborne ISR...
$6,950.00
Special Price $5,212.50 save 25 %
-
02 Mar 2021  |  North America  |  Market Outlook
Developing Innovative ROI Streams and Patient-centric Virtual Care Approaches will Shape the Global Healthcare Industry, Outlook 2021
Digital Transformation Leads to New Growth Strategies for Stakeholders
The global COVID-19 pandemic and other geo-political events left many businesses facing an unprecedented state of uncertainty. Healthcare companies across the care continuum remain grappling with these new challenges, of which the extent and longevity remain unknown. Spurred by the years events, healthcare delivery has accelerated its transformatio...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Dec 2018  |  North America  |  Market Outlook
Global Healthcare Market Outlook, 2019
With the Rise in Focus on Value-based Care, Technology Convergence will Drive Care Delivery Innovation
Globally, 2019 will be a year of value-based care, as ‘outcome-based care’ focus will globalize. This will trigger the maturation of risk-sharing in solution contracting between providers and drug/device OEMs, driving business value for providers. Access to affordable and quality care will be key political agendas for the upcoming 2019 elections in...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Dec 2022  |  Global  |  Technology Research
Companion Diagnostics (CDx): Technology Innovation and Growth Opportunities
The Transition to Precision Medicine is Propelling the Adoption of CDx Platforms.
The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...
$4,950.00
Special Price $3,712.50 save 25 %